<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Lund: Judging Session</title>
        <link>https://video.igem.org/videos/watch/814cbb18-c9c4-47c4-b720-223fe35548b8</link>
        <description>Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as Polycystic Ovary Syndrome (PCOS), affects millions of women worldwide, with hyperandrogenism being a key driver of symptoms such as irregular periods, acne, and an increased risk of type 2 diabetes. To address the lack of therapeutically precise treatments, iGEM Lund 2026 is developing a proof-of-concept synthetic biology platform designed to tackle androgen excess locally within the gut. By engineering a bacterial strain to express androgen-metabolizing enzymes under the control of a gut-responsive transcriptional switch, our system aims to convert excess androgens into less bioactive metabolites. Our project seeks to contribute on two fronts simultaneously: improving pathophysiological understanding of PMOS and exploring potential management strategies.</description>
        <lastBuildDate>Fri, 20 Nov 2026 21:53:13 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>Lund: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/814cbb18-c9c4-47c4-b720-223fe35548b8</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=814cbb18-c9c4-47c4-b720-223fe35548b8" rel="self" type="application/rss+xml"/>
    </channel>
</rss>